Long Position on SRDX @ $20.32 on 12/12/2012 (Rumor)

SurModics (SRDX) provides drug delivery and surface modification technologies to the healthcare industry.

The company offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, and urology markets.

It also provides a range of drug delivery technologies for injectable therapeutics, including microparticles, nanoparticles, and implants addressing a range of clinical applications, such as ophthalmology, oncology, dermatology, and neurology.

In addition, the company provides in vitro diagnostic component products and technologies comprising microarray slide technologies, protein stabilization reagents, substrates, polymers and reagent chemicals, and antigens for diagnostic test kits and biomedical research applications. SurModics, Inc. markets its technologies and products worldwide through direct sales force consisting of sales professionals.

We are now hearing rumors of good news for this company. One of the rumors states that this stock will be named by the leading stock advisory service as one of its "top picks." This service is widely followed by mutual funds and institutional money managers. These investors have portfolios that mimic recommendations of this service. Their naming of the stock should lead to additional demand for the shares. This is low float stock. Be sure to use a limit order. 

52-Week Trading Range:  $12.76 - $22.21

Last Trade:  $20.32

Stop Loss:  $19.10

Target Price:  $22.35

Position closed on 1/2/2013 at price of $23.00 with a 13.19% gain in 20 days.

Back to Portfolio